Cambium Bio Limited has released a press release.
Regeneus to present at FNN Virtual Investor Event
Filed with ASX · · 22 pages · English
6ix is checking which company filed this.
Earlier from Cambium Bio
- US Patent for Sygenus
- Regeneus and Kyocera sign Progenza OA deal
- Progenza OA Kyocera negotiations update
- Kyocera completes Progenza Due Diligence
- Appendix 4C Updated
Later from Cambium Bio
- Appendix 4E and Annual Report
- Regeneus receives milestone payment from Kyocera
- Regeneus to be granted new Sygenus patent in Canada
- Regeneus receives $5.6M milestone payment from Kyocera
- CEO Appointment and Resignation
Follow Cambium Bio into a list and get an email when it puts out news.
Follow Cambium Bio